Sandbox metoprolol: Difference between revisions

Sandbox metoprolol®
Black Box Warning
Adult Indications and Dosage FDA-Labeled Use; Off-Label Use
Pediatric Indications and Dosage FDA-Labeled Use; Off-Label Use
Contraindications
Warnings
Adverse Reactions Clinical Trials Experience; Postmarketing Experience
Drug Interactions
Use in Specific Populations Pregnancy; Labor and Delivery; Nursing Mothers; Pediatric Use; Geriatric Use; Gender; Race; Renal Impairment; Hepatic Impairment; Females of Reproductive; Potential and Males; Immunocompromised Patients
Routes and Preparations Routes; Preparations
IV Compatibility
Overdosage
Pharmacology Mechanism of Action; Structure; Pharmacodynamics; Pharmacokinetics; Nonclinical Toxicology
Clinical Studies
How Supplied
Images Drug Images; Package & Label Display Panel
Patient Information Patient Information from FDA; Patient Information from NLM
Combined Alcohol Use
Look-Alike Drug Names
Drug Shortage Status
Price

VisualWikitext

Revision as of 19:33, 14 March 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

For patient information about metoprolol, click here.

Synonyms / Brand Names: Lopressor, Toprol XL

Overview

Metoprolol is a selective β₁ receptor blocker used in treatment of several diseases of the cardiovascular system, especially hypertension. The active substance metoprolol is employed either as metoprolol succinate or as metoprolol tartrate (where 100 mg metoprolol tartrate corresponds to 95 mg metoprolol succinate). The tartrate is an immediate-release and the succinate is an extended-release formulation.^[1]

FDA Package Insert

Lopressor (metoprolol tartrate) tablet

Toprol XL (metoprolol succinate) tablet, extended release

Taking Alcohol with Metoprolol

Alcohol-Metoprolol interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

References

↑ Cupp M (2009). "Alternatives for Metoprolol Succinate" (pdf). Pharmacist's Letter / Prescriber's Letter. 25 (250302).

[1] Cupp M (2009). "Alternatives for Metoprolol Succinate" (pdf). Pharmacist's Letter / Prescriber's Letter. 25 (250302).

[1]

@@ Line 1: / Line 1: @@
+<div style="width: 80%;">
 __NOEDITSECTION____NOTOC__
-{{Metoprolol}}
+{{Lopressor}}
 {{CMG}}
+'''''For patient information about metoprolol, click [[metoprolol (patient information)|here]].'''''
+{{SB}} Lopressor, Toprol XL
 ==Overview==
@@ Line 13: / Line 18: @@
 ==FDA Package Insert==
-===[[Lopressor|Lopressor (metoprolol tartrate) tablet]]===
+===[[Sandbox Lopressor|Lopressor (metoprolol tartrate) tablet]]===
-===[[Toprol XL|Toprol XL (metoprolol succinate) tablet, extended release]]===
+===[[Sandbox Toprol XL|Toprol XL (metoprolol succinate) tablet, extended release]]===
 ==Taking Alcohol with Metoprolol==
 Alcohol-Metoprolol interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
-<div class="mw-collapsible mw-collapsed">
-==Professional Extension==
-<div class="mw-collapsible-content">
-[[{{PAGENAME}}#Guidelines & Evidence Based Medicine Resources|Guidelines & Evidence Based Medicine Resources]]
-<BR><BR>
-[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=search&db=pubmed&term={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} Most Recent Articles on {{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}]
-<BR><BR>
-[http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&db=pubmed&term={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}%20AND%20systematic%5Bsb%5D  Review Articles on {{PAGENAME}}]
-<BR><BR>
-[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&db=pubmed&term={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}+AND+%28%28N+Engl+J+Med%5Bta%5D%29+OR+%28Lancet%5Bta%5D%29+OR+%28BMJ%5Bta%5D%29%29 Articles on {{PAGENAME}} in N Eng J Med, Lancet, BMJ]
-[http://books.google.com/books?ie=UTF-8&oe=utf-8&q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&qt_s=Search&sa=N&tab=gp Textbook Information on {{PAGENAME}}]
-<BR><BR>
-[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&db=pubmed&term={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}+AND+%28randomized+controlled+trial%5BPublication+Type%5D+OR+%28randomized%5BTitle%2FAbstract%5D+AND+controlled%5BTitle%2FAbstract%5D+AND+trial%5BTitle%2FAbstract%5D%29%29 Trial Results with {{PAGENAME}}]
-<BR><BR>
-[http://www.guideline.gov/search/searchresults.aspx?Type=3&txtSearch={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&num=20 US National Guidelines Clearinghouse on {{PAGENAME}}]
-<BR><BR>
-[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&db=pubmed&term={{urlencode:({{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}) AND (Cochrane Database Syst Rev[ta])}} Cochrane Collaboration on {{PAGENAME}}]
-<BR><BR>
-[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&db=pubmed&term={{urlencode:({{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}) AND (Cost effectiveness)}} Cost Effectiveness of {{PAGENAME}}]
-</div></div>
 ==References==
@@ Line 50: / Line 30: @@
 {{reflist|2}}
+[[Category:Antianginals]]
+[[Category:Antiarrhythmic agents]]
+[[Category:Antihypertensive agents]]
+[[Category:Antimigraine drugs]]
 [[Category:Beta blockers]]
 [[Category:Cardiovascular Drugs]]
-[[Category:Drugs]]